Navigation Links
Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants

Safety of silicone gel breast implants have sparked off doubts in the researchers after potentially harmful levels of the metal platinum was found// in some of the women who were sporting silicone implants for a number of years.

This discovery is not perfect timing, uncannily close to the permission due to be accorded by the Food and Drug Administration, that will allow silicone implants to make a comeback into the markets for unconditional sale.

The journal of the American Chemical Society has carried two reports that have placed on record, high levels of platinum salts in the urine, hair and breast milk of 16 women with silicone gel implants, which carries a potential risk of allergic or toxic reactions.

Chemists, who are in the implant maker’s circuit, are up in arms against the FDA inferences on this matter, and they have reiterated that the platinum that is used in the silicone gel implants are in an inert form, incapable of causing harm.

Lykissa, a forensic toxicologist with the firm ExperTox said, "Implant manufacturers have said for years that their platinum is not harmful, and when the device is manufactured, they are correct. But in the body, we know that the implants degrade and the platinum can disperse and take on a more reactive form."

Amidst the furore, FDA spokeswoman Susan Cruzan has confirmed that they are debating the article threadbare and reviewing its contents, and it might take a while before anything conclusive comes out.
'"/>




Page: 1

Related medicine news :

1. Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains
2. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
3. WATCHs 2006 List Of Ten Potentially - Dangerous Toys
4. Jefferson Physicians Report on Potentially Fatal Complication of Heart Attack
5. Potentially Pathogenic Virus Found in Mad Cow Cells
6. Newborns With Respiratory Distress Potentially Have Rare Genetic Disease
7. FDA Urgently Warns Consumers About Health Risks of Potentially Contaminated Olives
8. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
9. Dangerous food bacteria
10. Breaking up Dangerous Clots
11. Weight-loss Products Dangerous
Post Your Comments:
(Date:4/24/2015)... 2015 Carinsurancequotesinfo.com has released a new ... how to qualify for auto insurance as ... for auto insurance online, without having to follow a ... single parents can reduce their auto insurance expenses. The ... properly explained. , Clients can now visit an ...
(Date:4/24/2015)... Vancouver, BC (PRWEB) April 24, 2015 ... Albert Yuzpe, Olive Fertility co-founder and co-director, has been ... Fertility Preservation at the Evening of Hope Gala. ... to recognize Dr. Albert Yuzpe, who has been at ... past 43 years,” says Jessica Séguin, Executive Director of ...
(Date:4/24/2015)... Insuranceautoquote.info has released a new blog ... . , Lowering auto insurance prices is not ... find better offers for their financial budget. Comparing prices ... not require any registration. , Comparing quotes can ... multiple agencies that sell coverage and this means that ...
(Date:4/24/2015)... April 24, 2015 “ Opera ” was ... which features the latest and coolest technology products available to ... NewsWatch, conducted the review and shared with viewers how this ... web browsers, surfing the internet would not be in existence. ... and the Opera browser is no different. Celebrating their 20th ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Eastern Star Masonic ... new Community Room on Sunday April 26th from 1:30-3:00 pm. ... to attend the ribbon cutting and grand opening of the ... will be on hand to offer tours to anyone who ... community. , The new community room will be available for ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2
... Data Can Be Integrated with Other Sales & ... Key Performance Indicators, Dynamic Graphs, And Custom Metrics ... leader in pharmaceutical data analysis and reporting solutions, ... within InView, the company,s graphical interactive portal for ...
... April 29 New analyses of data from ... beta-1b), sponsored by Bayer HealthCare Pharmaceuticals, were presented ... Annual Meeting. The study results showed that ... participants with multiple sclerosis (MS) were more likely ...
... warns more deaths are likely , , WEDNESDAY, April 29 ... become the first U.S. fatality in the spreading swine ... Dr. Richard Besser, acting director of the U.S. Centers ... other details on the case were immediately available, according ...
... Diluted Earnings per Share were $0.89, , Consistent ... Excluding Certain Significant Items, Increased 1% to $0.95- Worldwide ... , Increased 2%, Excluding the Impact of Foreign Exchange ... , Exchange, was Driven by Increases of 23% ...
... vs. $25.2 million - Increase of 34%Record Quarterly Diluted EPS: $0.17 vs. ... OWINGS MILLS, Md., April 29 Medifast, Inc. (NYSE: MED ... 31, 2009. First Quarter highlights included: , , ... quarter revenues increased 34% compared to 2008 to $33.7 million; , ...
... consider healthy hearing for spring 2009 , ... Stäfa, ... spring marks an opportunity for Americans to refresh and revitalize themselves. ... global initiative to inform and educate the public about the importance ...
Cached Medicine News:Health News:Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 3Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 4Health News:U.S. Reports First Swine Flu Death 2Health News:U.S. Reports First Swine Flu Death 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 2Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 4Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 5Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 6Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 7Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 8Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 9Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 10Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 11Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 12Health News:Medifast Reports Record First Quarter 2009 Financial Results 2Health News:Medifast Reports Record First Quarter 2009 Financial Results 3Health News:Medifast Reports Record First Quarter 2009 Financial Results 4Health News:Medifast Reports Record First Quarter 2009 Financial Results 5Health News:Medifast Reports Record First Quarter 2009 Financial Results 6Health News:Medifast Reports Record First Quarter 2009 Financial Results 7Health News:Medifast Reports Record First Quarter 2009 Financial Results 8Health News:Medifast Reports Record First Quarter 2009 Financial Results 9Health News:This Spring, Hear the World 2Health News:This Spring, Hear the World 3
(Date:4/23/2015)... 24, 2015  AbbVie (NYSE: ABBV ) has ... has accepted its New Drug Application (NDA) and granted ... antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin ... with chronic genotype 4 (GT4) hepatitis C virus (HCV) ... interferon-free therapy being evaluated by the FDA for patients ...
(Date:4/23/2015)... Health Canada is working with the Canadian manufacturers of ... regarding the risk of serious cardiovascular side effects (e.g., ... at high doses (at or above 2400 mg/day). This ... Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used ... The majority of ibuprofen products in Canada ...
(Date:4/23/2015)... BOULDER, Colo. , Apr. 23, 2015 /PRNewswire/ ... engineers, manufactures, and distributes state-of-the art equipment and ... specialization in commercial indoor cannabis cultivation, will host ... on Monday, April 27, 2015, at 4:15 PM ... The conference call will be listen-in ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
Inquire...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
... The StaRRsed Compact is a system ... human blood samples. This rate may ... patients therapy. The sedimentation rate is ... hence is typically used in high-volume ...
Medicine Products: